PDCD1 and lymphoma: This study showed that PD-1/CTLA-4 blockade can enhance the ability of cord blood T cells to control EBV-induced lymphoma growth and suggested that PD-1/CTLA-4 blockade may be useful in the treatment of some human EBV-induced diseases.